Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Bibliographic Details
Title: Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
Authors: Chowdary, P. *, Lethagen, S., Friedrich, U., Brand, B., Hay, C., Abdul Karim, F., Klamroth, R., Knoebl, P., Laffan, M., Mahlangu, J., Miesbach, W., Dalsgaard Nielsen, J., Martín‐Salces, M., Angchaisuksiri, P.
Source: In Journal of Thrombosis and Haemostasis May 2015 13(5):743-754
Database: ScienceDirect
More Details
ISSN:15387836
DOI:10.1111/jth.12864
Published in:Journal of Thrombosis and Haemostasis
Language:English